Xanodyne Pharmaceuticals - Ownership and Business Overview

Medical ProductsCompany

Xanodyne Pharmaceuticals Ownership

Who owns Xanodyne Pharmaceuticals?

.

Was Xanodyne Pharmaceuticals formerly PE-backed?

Yes. Xanodyne Pharmaceuticals was formerly owned by 3 private investors.

Xanodyne Pharmaceuticals Business Overview

Where is Xanodyne Pharmaceuticals headquartered?

Xanodyne Pharmaceuticals is headquartered in Newport, Kentucky.

What sector is Xanodyne Pharmaceuticals in?

Xanodyne Pharmaceuticals is a medical products company.

Medical Products M&A Summary in

Join Mergr to view all 0 acquisitions of medical products companies in , including .

Xanodyne Pharmaceuticals, Inc.

One Riverfront Place,
Newport, Kentucky 41071-4563
United States,
(859)371-6383
www.xanodyne.com

Xanodyne Pharmaceuticals is a fully integrated, branded specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women?s health and pain management.


 Subscribe to unlock this and 209,748
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.